In 2023, the Spinal Injectable Market is expected to be worth US$23.3 billion. The market is expected to exceed US$ 51.2 billion by 2033, growing at an 8.2% CAGR during the forecast period. Because of the exponentially increasing prevalence of chronic lower back pain, the global market for spinal injectables is expe.
According to the report published by Allied Market Research, the global dystonia drugs market was valued at $806.67 million in 2021, and is projected to reach $1,378.67 million by 2031, registering a CAGR of 5.5% from 2022 to 2031. The study analyzes the important strategies, drivers, competition, market dynamics, s.